← Back
$SGMO All transactions

SANGAMO THERAPEUTICS, INC

A

$ Value

$0

Shares

800,000

Price

$0

Filed

Apr 3

Insider

Name

Dubois-Stringfellow Nathalie

Title

SVP-CHIEF DEVELOPMENT OFFICER

CIK

0001947007

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

800,000

Footnotes

One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.

Filing Info

Accession No.

0001947007-26-000006

Form Type

4

Issuer CIK

0001001233

Dubois-Stringfellow Nathalie's History

Date Ticker Type Value
2026-04-21 SGMO $89K
2026-04-01 SGMO A $0
2025-05-24 SGMO F $848
2025-04-22 SGMO F $25K

Other Insiders at SGMO (90d)

Insider Bought Sold Last
Macrae Sandy
PRESIDENT, CEO AND DIRECTOR
2026-04-01
Willoughby Scott B.
SVP, CHIEF LEGAL OFFICER, SECY
2026-04-01
Dubois-Stringfellow Nathalie
SVP-CHIEF DEVELOPMENT OFFICER
$89K 2026-04-21
Davis Gregory D
Head of Research & Technology
$18K 2026-04-22
Jain Nikunj
Principal Accounting Officer
2026-04-01